back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-06-18 16:31 Tx date 2025-06-15 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,810
+368 vol $4.92 each |
30,520 | |
| Filed 2025-06-18 16:30 Tx date 2025-06-15 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,009
+1,326 vol $6.04 each |
30,152 | |
| Filed 2025-04-04 18:47 Tx date 2025-04-01 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$31,448
+5,097 vol $6.17 each |
28,826 | |
| Filed 2025-04-04 18:45 Tx date 2025-04-01 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
57 - Exercise of rights
|
$-45,498.93
-8,733 vol $5.21 each |
35,326 | |
| Filed 2025-04-04 18:43 Tx date 2025-04-01 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
$-22,752.07
-4,367 vol $5.21 each |
17,663 | |
| Filed 2025-03-29 16:22 Tx date 2025-03-24 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$37,427
+6,027 vol $6.21 each |
22,030 | |
| Filed 2025-03-29 16:21 Tx date 2025-03-24 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$74,849
+12,053 vol $6.21 each |
44,059 | |
| Filed 2025-03-29 16:20 Tx date 2025-03-24 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$114,773
+18,482 vol $6.21 each |
83,100 | |
| Filed 2025-03-20 15:45 Tx date 2025-03-15 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,501
+298 vol $5.04 each |
23,729 | |
| Filed 2025-03-20 15:43 Tx date 2025-03-15 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,583
+1,101 vol $5.98 each |
23,431 | |
| Filed 2024-12-18 12:08 Tx date 2024-12-15 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,432
+1,800 vol $5.24 each |
22,330 | |
| Filed 2024-09-18 14:18 Tx date 2024-09-15 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$377.21
+67 vol $5.63 each |
20,530 | |
| Filed 2024-09-18 14:17 Tx date 2024-09-15 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,578
+1,115 vol $5.90 each |
20,463 | |
| Filed 2024-06-19 21:02 Tx date 2024-06-15 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$438.48
+84 vol $5.22 each |
19,348 | |
| Filed 2024-06-19 21:01 Tx date 2024-06-15 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,538
+1,302 vol $5.79 each |
19,264 | |
| Filed 2024-04-25 14:07 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$104,201
+18,217 vol $5.72 each |
64,618 | |
| Filed 2024-04-16 18:23 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$103,398
+18,140 vol $5.70 each |
||
| Filed 2024-04-16 18:26 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$35,659
+6,256 vol $5.70 each |
16,003 | |
| Filed 2024-04-16 18:24 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$71,324
+12,513 vol $5.70 each |
32,006 | |
| Filed 2024-04-16 18:23 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$103,398
+18,140 vol $5.70 each |
64,541 | |
| Filed 2024-04-05 16:07 Tx date 2024-04-01 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$31,174
+5,882 vol $5.30 each |
17,962 | |
| Filed 2024-04-05 16:05 Tx date 2024-04-01 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
57 - Exercise of rights
|
$-43,748.37
-8,397 vol $5.21 each |
19,493 | |
| Filed 2024-04-05 16:04 Tx date 2024-04-01 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
$-21,876.79
-4,199 vol $5.21 each |
9,747 | |
| Filed 2024-04-05 15:31 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$43,748
+8,397 vol $5.21 each |
8,397 | |
| Filed 2024-04-05 15:27 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$21,876
+4,199 vol $5.21 each |
4,199 | |
| Filed 2022-04-27 10:27 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$43,748
+8,397 vol $5.21 each |
||
| Filed 2022-04-27 10:26 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$21,876
+4,199 vol $5.21 each |
||
| Filed 2022-01-06 16:03 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$21,876
+4,199 vol $5.21 each |
||
| Filed 2022-01-06 16:02 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$43,748
+8,397 vol $5.21 each |
||
| Filed 2021-12-10 14:04 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$43,748
+8,397 vol $5.21 each |
||
| Filed 2021-12-10 14:03 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$21,876
+4,199 vol $5.21 each |
||
| Filed 2024-03-19 20:20 Tx date 2024-03-15 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,667
+1,258 vol $5.30 each |
12,080 | |
| Filed 2023-12-19 10:37 Tx date 2023-12-15 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,347
+1,413 vol $5.20 each |
10,822 | |
| Filed 2023-09-19 11:26 Tx date 2023-09-15 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,302
+1,426 vol $4.42 each |
9,409 | |
| Filed 2023-06-19 14:57 Tx date 2023-06-15 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,247
+1,473 vol $4.92 each |
7,983 | |
| Filed 2023-06-19 13:40 Tx date 2023-06-15 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,252
+1,474 vol $4.92 each |
||
| Filed 2023-06-19 13:40 Tx date 2023-06-15 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,252
+1,474 vol $4.92 each |
7,984 | |
| Filed 2023-04-03 21:41 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$23,887
+5,380 vol $4.44 each |
18,144 | |
| Filed 2023-04-03 21:40 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$47,774
+10,760 vol $4.44 each |
23,692 | |
| Filed 2023-04-03 21:38 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$76,954
+17,332 vol $4.44 each |
46,401 | |
| Filed 2023-03-19 23:08 Tx date 2023-03-15 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,997
+1,190 vol $5.04 each |
6,510 | |
| Filed 2022-12-23 15:59 Tx date 2022-12-19 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,998
+1,318 vol $5.31 each |
5,320 | |
| Filed 2022-09-21 16:31 Tx date 2022-09-15 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,503
+267 vol $5.63 each |
4,002 | |
| Filed 2022-06-17 21:53 Tx date 2022-06-15 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,748
+335 vol $5.22 each |
3,735 | |
| Filed 2022-04-27 10:27 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$43,748
+8,397 vol $5.21 each |
8,397 | |
| Filed 2022-04-27 10:26 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$21,876
+4,199 vol $5.21 each |
4,199 | |
| Filed 2022-01-06 16:03 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$21,876
+4,199 vol $5.21 each |
||
| Filed 2022-01-06 16:02 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$43,748
+8,397 vol $5.21 each |
||
| Filed 2021-12-10 14:04 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$43,748
+8,397 vol $5.21 each |
||
| Filed 2021-12-10 14:03 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$21,876
+4,199 vol $5.21 each |
||
| Filed 2022-03-29 11:21 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$22,752
+4,367 vol $5.21 each |
8,566 | |
| Filed 2022-03-29 11:20 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$45,498
+8,733 vol $5.21 each |
17,130 | |
| Filed 2022-03-29 11:20 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$77,649
+14,904 vol $5.21 each |
29,069 | |
| Filed 2022-01-06 21:49 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$74,507
+14,165 vol $5.26 each |
14,165 | |
| Filed 2022-01-06 16:03 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$21,876
+4,199 vol $5.21 each |
4,199 | |
| Filed 2022-01-06 16:02 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$43,748
+8,397 vol $5.21 each |
8,397 | |
| Filed 2022-01-06 15:48 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$80,904
+15,381 vol $5.26 each |
15,381 | |
| Filed 2022-01-06 15:48 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$80,904
+15,381 vol $5.26 each |
||
| Filed 2021-12-10 14:04 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$43,748
+8,397 vol $5.21 each |
||
| Filed 2021-12-10 14:03 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$21,876
+4,199 vol $5.21 each |
||
| Filed 2021-12-10 14:01 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$80,904
+15,381 vol $5.26 each |
||
| Filed 2021-12-10 14:01 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$80,904
+15,381 vol $5.26 each |
||
| Filed 2021-12-10 14:04 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$43,748
+8,397 vol $5.21 each |
8,397 | |
| Filed 2021-12-10 14:03 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-10 14:03 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$21,876
+4,199 vol $5.21 each |
4,199 | |
| Filed 2021-12-10 14:02 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-10 14:01 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$80,904
+15,381 vol $5.26 each |
15,381 | |
| Filed 2021-12-10 14:01 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-09-02 18:24 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
3,400 |